CAR T cells targeting αvβ3 integrin are effective against advanced cancer in preclinical models.

Lars WallstabeAndreas MadesSilke FrenzHermann EinseleChristoph RaderMichael Hudecek
Published in: Advances in cell and gene therapy (2018)
αvβ3-CAR T-cells have therapeutic potential in several prevalent solid tumours, including melanoma and triple-negative breast cancer.